Physician profile
Rahul Sharma
NPI 1063675288
$195,086.97
in general payments reported to CMS, 2019-2025
33 companies · $15K in 2025
The $15K reported for 2025 was more than what 91% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,077 · 2020: $358 · 2021: $5,048 · 2022: $39K · 2023: $98K · 2024: $31K · 2025: $15K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $94K · Travel and Lodging: $34K · Food and Beverage: $12K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $2,625 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,000 · Long Term Medical Supply Or Device Loan: $282.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $93,734.82 |
| Travel and Lodging | $33,595.37 |
| Food and Beverage | $12,431.50 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $2,625.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,000.00 |
| Long Term Medical Supply Or Device Loan | $281.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $139,305.35 | 2019-2025 | Amplatzer Amulet, Navitor, Mitraclip |
| Edwards Lifesciences Corporation | $26,744.37 | 2019-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Sapien 3 Ultra Resilia, Pascal |
| Medtronic, INC. | $7,385.88 | 2021-2025 | Corevalve Evolut R, Resolute Onyx, Cobalt Dr Mri Surescan |
| Cathworks, INC. | $5,250.00 | 2024 | Ffrangio |
| Boston Scientific Corporation | $4,189.48 | 2019-2025 | Watchman Access System, Watchman, Watchman Flx |
| Cardiva Medical, INC. | $4,105.75 | 2022-2024 | Savvywire, Cardiva Vascade Mvp Vvcs 6-12f |
| Ancora Heart, INC. | $2,324.54 | 2019 | |
| Medtronic Vascular, INC. | $1,462.00 | 2019-2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $1,160.38 | 2021-2025 | Lifevest |
| Abiomed | $1,115.87 | 2020-2025 | Impella |
| Philips North America LLC | $457.30 | 2024 | (Ao0) Igt Devices Intracardiac, (9520) Igt Devices Undivided |
| Cardiovascular Systems INC. | $350.47 | 2021 | |
| W. L. Gore & Associates, INC. | $171.98 | 2019 | |
| Novartis Pharmaceuticals Corporation | $128.80 | 2021-2025 | |
| Biosense Webster, INC. | $114.23 | 2022-2023 | Na |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Heartflow, INC. | $108.31 | 2023 | Ffrct |
| E.R. Squibb & Sons, L.L.C. | $93.26 | 2023-2025 | Eliquis, Camzyos |
| Genzyme Corporation | $70.00 | 2019 | |
| Jenavalve Technology, INC. | $69.73 | 2023 | Jenavalve Pericardial Tavr System |
| Chiesi USA, INC. | $57.04 | 2021-2024 | Kengreal, Cleviprex |
| Baylis Medical Company INC | $50.35 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $45.83 | 2023-2025 | Farxiga |
| Alnylam Pharmaceuticals INC. | $41.07 | 2023-2025 | Amvuttra |
| Bayer Healthcare Pharmaceuticals INC. | $39.57 | 2025 | |
| Pfizer INC. | $33.86 | 2023-2025 | |
| Actelion Pharmaceuticals US, INC. | $32.95 | 2025 | Opsumit |
| Atricure, INC. | $31.27 | 2022-2023 | |
| Janssen Pharmaceuticals, INC | $30.98 | 2024 | Xarelto |
| Boehringer Ingelheim Pharmaceuticals, INC. | $28.70 | 2024 | Jardiance |
| Kestra Medical Technology Services, INC. | $27.81 | 2024 | Assure Wcd |
| Merck Sharp & Dohme LLC | $26.04 | 2025 | Verquvo |
| Amgen INC. | $18.97 | 2022 | |
| Novo Nordisk INC | $14.83 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rahul Sharma listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.